Categories Earnings, Health Care

Mallinckrodt plc (MNK): Q3 2019 Earnings Snapshot

—  Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected.

— Revenue fell 7% to $743.7 million, vs. $770.8 million expected. Acthar Gel net sales were $229.8 million, down 20.8% YoY.

— Raised fiscal year 2019 adjusted EPS guidance range to $8.50 – $8.70, from the prior estimate of $8.40 – $8.70

— MNK shares rose 2.3% immediately following the announcement.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Should investors worry about Micron’s (MU) weak Q4 results and guidance?

The semiconductor industry is a rapidly growing business segment that currently thrives on the digital transformation wave. The demand for memory chips and other semiconductor products increased over the years,

What has Bed Bath & Beyond (BBBY) outlined for this fiscal year?

Shares of Bed Bath & Beyond (NASDAQ: BBBY) were up on Friday, a day after the company delivered disappointing results for the second quarter of 2022. The company reported a

NKE Earnings: Highlights of Nike’s Q1 2023 results

Nike, Inc. (NYSE: NKE) has reported a decrease in net profit for the first quarter of 2023, despite a modest increase in revenues. The company's stock suffered a big loss

Add Comment
Viewing Highlight